Escaping to Europe By Eric Pierce
& Shaun Brown
Staff Writers

Although the upward trend in biotech share prices is providing some glimmers of encouragement - after a third consecutive weekly gain the BioCentury 100 index is up 28 percent since Sept. 4 - the grass still looks greener in Europe for companies in need of cash.